Joel Raskin, MD
- 7Articles
- 20.6KReads
- 2001–2014Active
- 36Collaborators
- 6Citations
About
Joel Raskin, MD, has published extensively on the clinical use of duloxetine in treating major depressive disorder, generalized anxiety disorder, and associated pain symptoms. His work includes studies on suicidal ideation, fall risk in older adults, and long-term treatment outcomes. Raskin has also explored pharmacokinetic and therapeutic effects of combining antidepressants, as well as rapid tranquilization in acute psychosis. His research spans psychiatry, neurology, primary care, and somatoform disorders.
Publications
Suicidal Thoughts and Reasons for Living in Hospitalized Patients With Severe Depression: Post-Hoc Analyses of a Double-Blind Randomized Trial of Duloxetine
June 15, 2014
Assessment of Falls in Older Patients Treated With Duloxetine: A Secondary Analysis of a 24-Week Randomized, Placebo-Controlled Trial
January 3, 2013
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
